Daniel Hoft, M.D., Ph.D., Director of the Division of Infectious Diseases, has received a grant from the National Institute of Allergy and Infectious Diseases at the NIH to study immune responses to Zika virus infection. The study will be conducted in conjunction with other Vaccine Treatment and Evaluation Units at Emory University and Baylor College of Medicine.

The Centers will recruit volunteers who have traveled to or had sexual contact with someone who traveled to areas where Zika is prevalent, and who have been diagnosed with or had symptoms of Zika infection. Researchers at SLU will analyze blood specimens from these volunteers in order to assess the body’s immune response to infection. Understanding how the virus works and how the body responds to infection could help scientists develop better treatments and more effective vaccines for the virus.

For more information, read the full article in Newslink.